Prevention of the development of melphalan resistance in vitro by selenite

Biol Trace Elem Res. 1998 Dec;65(3):187-95. doi: 10.1007/BF02789095.


Exposure of A2780 human ovarian tumor cells to a low concentration of melphalan in vitro for 7 d results in the development of melphalan resistance, which is dependent on elevated cellular levels of glutathione and glutathione S-transferase. The inclusion of selenite (at concentrations as low as 0.2 microM) during the exposure to melphalan completely prevented the development of resistance. Selenite did not prevent the melphalan-induced increase in glutathione, but it did prevent the increase in the activity of glutathione S-transferase. It also prevented the increase in the expression of the glutathione S-transferase gene, suggesting that this may be the mechanism by which it prevents the development of melphalan resistance. The results of this in vitro study suggest that selenite may prove to be useful in preventing the development of drug resistance in vivo.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents, Alkylating / pharmacology*
  • Blotting, Northern
  • Cell Division / drug effects
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Resistance, Neoplasm
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Glutathione Transferase / drug effects
  • Glutathione Transferase / genetics
  • Glutathione Transferase / metabolism
  • Humans
  • Melphalan / pharmacology*
  • Ovarian Neoplasms / drug therapy*
  • RNA, Messenger / analysis
  • Sodium Selenite / pharmacology*
  • Tumor Cells, Cultured / drug effects


  • Antineoplastic Agents, Alkylating
  • RNA, Messenger
  • Glutathione Transferase
  • Sodium Selenite
  • Melphalan